ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Advanced Search

Experience with Alemtuzumab Induction with Tacrolimus/Mycophenolate +/- Steroids in Simultaneous Pancreas-Kidney Transplant Recipients with Portal-Enteric Drainage

D. Harriman, A. Farney, J. Rogers, G. Orlando, A. Reeves-Daniel, M. Gautreaux, W. Doares, S. Kaczmorski, R. Stratta.

Surgery, Medicine, Pathology, Pharmacy, Wake Forest Baptist Medical Center, Winston-Salem, NC.

Meeting: 2018 American Transplant Congress

Abstract number: A351

Keywords: Graft survival, Immunosuppression, Kidney/pancreas transplantation, Pancreas transplantation

Session Information

Date: Saturday, June 2, 2018

Session Name: Poster Session A: Pancreas and Islet: All Topics

Session Time: 5:30pm-7:30pm

 Presentation Time: 5:30pm-7:30pm

Location: Hall 4EF

Related Abstracts
  • Steroid Avoidance with Alemtuzumab Induction and Tacrolimus Monotherapy Gives Similar Outcomes to Basiliximab Induction with Tacrolimus / Mycophenolate Maintenance at Three Years
  • Alemtuzumab Induction in Simultaneous Pancreas and Kidney Transplantation

Introduction: Simultaneous pancreas-kidney transplant (SPKT) recipients are a relatively homogeneous population that are considered high immunological risk because of younger age, presumed autoimmune etiology of diabetes, erratic drug absorption due to gastroparesis, and inherent immunogenicity of the pancreas graft. At present, <30% of SPKT in the US undergo early steroid withdrawal (ESW) and <20% are performed with portal-enteric drainage or alemtuzumab (Alem) induction. The study purpose was to analyze our outcomes in primary SPKT recipients undergoing intent-to-treat portal-enteric drainage and Alem induction with tacrolimus (TAC)/mycophenolate (MP) maintenance therapy ± ESW. Methods: From 2005-2016, 120 primary SPKTs (107 portal-enteric drainage) were performed. All patients (pts) received single dose Alem (30 mg intra-operative) with TAC/MP ± steroids. ESW was performed unless pts were African-Americans (AA) <40 years old (n=22), sensitized with a panel reactive antibody >20% (n=12) or experienced kidney delayed graft function (n=4). Results: The study group included 85 Caucasian, 32 AA, and 3 other pts; 25 pts had pre-transplant C-peptide levels ≥2.0 ng/ml, suggesting a type 2 diabetes phenotype. Mean follow-up was 5 years. Overall pt, kidney and pancreas (insulin independence) graft survival rates were 90%, 79%, and 75%, respectively, and did not differ by ethnicity, pre-transplant C-peptide status, or in pts with ESW. ESW was attempted in 86 (72%) pts; 45 (52%) remain steroid-free. There were no significant differences between 1-year and overall rates of acute rejection (AR) in ESW (26%, 34%) versus non-ESW (n=34; 38%, 50%) pts. Death with functioning graft and AR/chronic rejection were the most common causes of kidney and pancreas graft loss. Most AR episodes were heralded by dose reduction in either TAC or MP because of infection or specific drug toxicities. Most pts could not tolerate full/therapeutic doses of TAC and MP, with 16 pts (13%) unable to tolerate either drug. Conclusion: Although ESW is feasible and durable in about half of appropriately selected SPKT pts, one must carefully weigh the benefits and risks of such a strategy, given that rates of AR are high and most diabetic pts cannot tolerate full doses of TAC and MP.

CITATION INFORMATION: Harriman D., Farney A., Rogers J., Orlando G., Reeves-Daniel A., Gautreaux M., Doares W., Kaczmorski S., Stratta R. Experience with Alemtuzumab Induction with Tacrolimus/Mycophenolate +/- Steroids in Simultaneous Pancreas-Kidney Transplant Recipients with Portal-Enteric Drainage Am J Transplant. 2017;17 (suppl 3).

  • Tweet
  • Email
  • Print

To cite this abstract in AMA style:

Harriman D, Farney A, Rogers J, Orlando G, Reeves-Daniel A, Gautreaux M, Doares W, Kaczmorski S, Stratta R. Experience with Alemtuzumab Induction with Tacrolimus/Mycophenolate +/- Steroids in Simultaneous Pancreas-Kidney Transplant Recipients with Portal-Enteric Drainage [abstract]. https://atcmeetingabstracts.com/abstract/experience-with-alemtuzumab-induction-with-tacrolimus-mycophenolate-steroids-in-simultaneous-pancreas-kidney-transplant-recipients-with-portal-enteric-drainage/. Accessed December 8, 2019.

« Back to 2018 American Transplant Congress

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Penis Transplantation: First U.S. Experience.
  • Evidence of a Clinically Significant Drug-Drug Interaction between Cannabidiol and Tacrolimus: A Case Report
  • Is There a Difference Between DCD and DBD Kidney Transplantation with Similar KDPI?
  • Low GFR after Kidney Donation Is Not Chronic Kidney Disease
  • Tacrolimus Dose and Trough Blood Levels in a US Liver Transplant Population
  • Penis Transplantation: First U.S. Experience.
  • Evidence of a Clinically Significant Drug-Drug Interaction between Cannabidiol and Tacrolimus: A Case Report
  • Is There a Difference Between DCD and DBD Kidney Transplantation with Similar KDPI?
  • Low GFR after Kidney Donation Is Not Chronic Kidney Disease
  • Tacrolimus Dose and Trough Blood Levels in a US Liver Transplant Population
  • Penis Transplantation: First U.S. Experience.
  • Is There a Difference Between DCD and DBD Kidney Transplantation with Similar KDPI?
  • Low GFR after Kidney Donation Is Not Chronic Kidney Disease
  • Evidence of a Clinically Significant Drug-Drug Interaction between Cannabidiol and Tacrolimus: A Case Report
  • Kidney Dialysis after Heart Transplantation: The Short and Long Term Outcomes

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2019 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy

wiley-new-logo

loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.
This site uses cookies: Find out more.